Related Experiment Video
Updated: Jun 17, 2026

Near-Infrared Spectroscopy During Reactive Hyperemia for the Assessment of Lower Limb Vascular Function
Published on: March 22, 2024
Effects of acute nitric oxide synthase inhibition on lower leg vascular function in chronic tetraplegia
Michael F La Fountaine1, Miroslav Radulovic, Christopher P Cardozo
1VA Center of Excellence on the Medical Consequences of Spinal Cord Injury, James J. Peters VA Medical Center, SCI Room 1E-02, 130 W. Kingsbridge Road, Bronx, NY 10468, USA. michael.lafountaine@gmail.com
Background/Objective:
To improve our understanding of the lower-leg vascular responses of nitric oxide synthase inhibition in persons with tetraplegia.
Participants:
Six people with chronic tetraplegia and 6 age-matched controls.
Methods:
Lower-leg relative vascular resistance and venous volume variation were obtained by venous occlusion plethysmography and blood pressure by auscultation at baseline. Postintravenous infusion of the nitric oxide synthase inhibitor NG-nitro-L-arginine-methyl-ester (1 mg x kg(-1) or placebo on separate days.
Results:
At baseline in the group with tetraplegia compared with controls, mean arterial pressure and relative vascular resistance of the leg were significantly lower. After nitric oxide synthase inhibition, mean arterial pressure and lower leg vascular resistance were significantly elevated in both groups. There were no group or intervention differences in venous volume variation.
Conclusion:
These preliminary results suggest that nitric oxide synthase inhibition with 1 mg x kg(-1) N(G)-nitro-L-arginine-methyl-ester normalizes seated blood pressure and lower leg vascular resistance to control group baseline levels.
Related Concept Videos
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care

